Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver
Clinical trial NCT03604016 · UNKNOWN
Trial details
- NCT number
- NCT03604016
- Sponsor
- IlDong Pharmaceutical Co Ltd
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-23
- Primary completion
- 2020-07-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.